Whole sample size (N = 47) | Placebo | Perilla | Placebo | Perilla | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Run In | Intake week 1-2 | Intake week 3-4 | p value (ANOVA) | Run In | Intake week 1-2 | Intake week 3-4 | p value (ANOVA) | Delta week 3-4 to run in | Delta week 3-4 to run in | Comparison between groups (95% CI) | |
Bloating | 1.45 | 1.44 | 1.2 | 0.0733 | 1.42 | 1.28 | 0.98 | 0.0003 | -0.25 | -0.44 | -0.194 to 0.562 |
SD | 0.74 | 0.72 | 0.77 | 0.81 | 0.64 | 0.78 | 0.71 | 0.56 | |||
Passage of gas | 1.47 | 1.57 | 1.37 | 0.2284 | 1.6 | 1.5 | 1.3 | 0.0264 | -0.10 | -0.30 | -0.177 to 0.577 |
SD | 0.66 | 0.53 | 0.62 | 0.77 | 0.62 | 0.74 | 0.62 | 0.66 | |||
GI rumbling | 1.51 | 1.33 | 1.18 | 0.0635 | 1.64 | 1.27 | 1.09 | 0.0014 | -0.33 | -0.55 | -0.251 to 0.685 |
SD | 0.86 | 0.91 | 0.83 | 0.85 | 0.6 | 0.81 | 0.71 | 0.87 | |||
Feeling of fullness | 1.08 | 1.05 | 0.83 | 0.0987 | 1.03 | 0.84 | 0.67 | 0.0152 | -0.24 | -0.36 | -0.288 to 0.515 |
SD | 0.8 | 0.59 | 0.62 | 0.77 | 0.63 | 0.63 | 0.64 | 0.72 | |||
Abdominal discomfort | 1.15 | 1.06 | 0.84 | 0.0345 | 1.25 | 0.92 | 0.71 | 0.0004 | -0.31 | -0.54 | -0.156 to 0.621 |
SD | 0.93 | 0.84 | 0.81 | 0.86 | 0.61 | 0.74 | 0.55 | 0.75 |